Katarzyna B. Lewandowska

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications

Statin use and its implications on survival and disease progression in the European MultiPartner idiopathic pulmonary fibrosis registry (EMPIRE).

Statin use and its implications on survival and disease progression in the European MultiPartner idiopathic pulmonary fibrosis registry (EMPIRE).

Journal: Annals of medicine
Published: March 19, 2026

Adverse side-effects of antifibrotic drugs in idiopathic pulmonary fibrosis-clarification of several points.

Adverse side-effects of antifibrotic drugs in idiopathic pulmonary fibrosis-clarification of several points.

Journal: Journal of thoracic disease
Published: February 25, 2026

Acute respiratory failure as a rare presentation of non-fibrotic hypersensitivity pneumonitis: Case series.

Acute respiratory failure as a rare presentation of non-fibrotic hypersensitivity pneumonitis: Case series.

Journal: Medicine
Published: October 30, 2025

Lung Transplantation in Idiopathic Pulmonary Fibrosis Patients in the European MultiPartner IPF Registry: Challenges for Health Equity.

Lung Transplantation in Idiopathic Pulmonary Fibrosis Patients in the European MultiPartner IPF Registry: Challenges for Health Equity.

Journal: Biomedicines
Published: September 19, 2025

Beyond corticosteroids: A systematic review and meta-analysis of novel therapies for hypersensitivity pneumonitis.

Beyond corticosteroids: A systematic review and meta-analysis of novel therapies for hypersensitivity pneumonitis.

Journal: Respiratory medicine
Published: July 13, 2025

AI-Assisted Simple Scoring Algorithm Was Helpful in the Risk Assessment of Cardiac Involvement in Patients with Pulmonary Sarcoidosis.

AI-Assisted Simple Scoring Algorithm Was Helpful in the Risk Assessment of Cardiac Involvement in Patients with Pulmonary Sarcoidosis.

Journal: Journal of clinical medicine
Published: July 10, 2025

Real-world treatment persistence and predictive factors for discontinuation of antifibrotic therapies in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of two multicenter observational cohort studies in Poland.

Real-world treatment persistence and predictive factors for discontinuation of antifibrotic therapies in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of two multicenter observational cohort studies in Poland.

Journal: Frontiers in pharmacology
Published: March 02, 2025

MUC5B Polymorphism in Patients with Idiopathic Pulmonary Fibrosis-Does It Really Matter?

MUC5B Polymorphism in Patients with Idiopathic Pulmonary Fibrosis-Does It Really Matter?

Journal: International journal of molecular sciences
Published: January 30, 2025

Adverse side-effects of antifibrotic drugs and outcome of treatment in idiopathic pulmonary fibrosis.

Adverse side-effects of antifibrotic drugs and outcome of treatment in idiopathic pulmonary fibrosis.

Journal: Journal of thoracic disease
Published: January 19, 2025

Assessment of lung function and severity grading in interstitial lung diseases (% predicted versus z-scores) and association with survival: A retrospective cohort study of 6,808 patients.

Assessment of lung function and severity grading in interstitial lung diseases (% predicted versus z-scores) and association with survival: A retrospective cohort study of 6,808 patients.

Journal: PLoS medicine
Published: September 23, 2024

Does a Type of Inciting Antigen Correlate with the Presence of Lung Fibrosis in Patients with Hypersensitivity Pneumonitis?

Does a Type of Inciting Antigen Correlate with the Presence of Lung Fibrosis in Patients with Hypersensitivity Pneumonitis?

Journal: Journal of clinical medicine
Published: July 14, 2024

Short- and long-term clinical outcomes of nintedanib therapy in IPF patients with different phenotypes: A retrospective registry-based study.

Short- and long-term clinical outcomes of nintedanib therapy in IPF patients with different phenotypes: A retrospective registry-based study.

Journal: Respiratory medicine
Published: February 21, 2024
Showing 1-12 of 47

Last Updated: 09/26/2026